2018
DOI: 10.7759/cureus.3461
|View full text |Cite
|
Sign up to set email alerts
|

Hypertriglyceridemic Pancreatitis: Is Insulin Monotherapy A Feasible Therapeutic Option?

Abstract: Hypertriglyceridemic pancreatitis (HTGP) is an uncommon but well-established clinical entity. Although the initial clinical features are similar to pancreatitis due to other etiologies, the severity of the disease and the risk of complications are higher in these patients. Prompt diagnosis and appropriate treatment are crucial in patients with hypertriglyceridemia-induced pancreatitis to avoid life-threatening complications. The initial conservative treatment is applied followed by additional specific therapie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 16 publications
(25 reference statements)
0
13
1
Order By: Relevance
“…Abdominal ultrasound ruled out the gallstones and other abnormalities in the gallbladder. Furthermore, her serum triglyceride levels were within normal limits and her urine pregnancy test was negative [ 29 ]. She had normal serum IgG4 levels, no history of prior pancreatitis episodes, and no evidence of IgG4-associated autoimmune systemic disease or concomitant inflammatory bowel disease.…”
Section: Discussionmentioning
confidence: 99%
“…Abdominal ultrasound ruled out the gallstones and other abnormalities in the gallbladder. Furthermore, her serum triglyceride levels were within normal limits and her urine pregnancy test was negative [ 29 ]. She had normal serum IgG4 levels, no history of prior pancreatitis episodes, and no evidence of IgG4-associated autoimmune systemic disease or concomitant inflammatory bowel disease.…”
Section: Discussionmentioning
confidence: 99%
“…Intravenous insulin infusion therapy has previously been used in these patients with promising outcomes to decrease serum triglyceride. 5 The mechanism by which insulin lowers the level of serum triglycerides is by enhancing lipoprotein lipase activity, an enzyme that accelerates chylomicron and very low-density lipoprotein metabolism to glycerol and FFAs. 14 15 Therefore, it ultimately decreases the serum triglyceride levels.…”
Section: Discussionmentioning
confidence: 99%
“…Treating the concurrent DKA is also crucial, as decreased insulin causes a rise in the triglyceride level in the blood, creating a hindrance in the management of HTG. The use of insulin in such cases is bifold, as it manages DKA while also improving HTG by activating lipoprotein lipase [ 7 ].…”
Section: Discussionmentioning
confidence: 99%